Listed

Supernus Pharmaceuticals, Inc.

SUPNNasdaqCIK 1356576HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$226.8m, Q3 FY2026
Operating income$21.2m, Q3 FY2026
Net income$20.9m, Q3 FY2026
Supernus Pharmaceuticals, Inc., income statement, quarterly
Line itemUnitperiod not labelled2023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Revenue$m164Revenue, period not labelled, three months to 2023-12-31$164.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure144Revenue, Q1 FY2024, three months to 2024-03-31$143.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0001356576-25-000033.Report this figure168Revenue, Q2 FY2024, three months to 2024-06-30$168.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-05, accession 0001356576-25-000055.Report this figure176Revenue, Q3 FY2024, three months to 2024-09-30$175.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure174Revenue, Q4 FY2024, three months to 2024-12-31$174.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure150Revenue, Q1 FY2025, three months to 2025-03-31$149.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure165Revenue, Q2 FY2025, three months to 2025-06-30$165.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure192Revenue, Q3 FY2025, three months to 2025-09-30$192.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure212Revenue, Q4 FY2025, three months to 2025-12-31$211.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure208Revenue, Q1 FY2026, three months to 2026-03-31$207.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure219Revenue, Q2 FY2026, three months to 2026-06-30$219.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure227Revenue, Q3 FY2026, three months to 2026-09-30$226.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure
Cost of revenue$m19.6Cost of revenue, period not labelled, three months to 2023-12-31$19.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure16.3Cost of revenue, Q1 FY2024, three months to 2024-03-31$16.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-06, accession 0001356576-25-000033.Report this figure17.9Cost of revenue, Q2 FY2024, three months to 2024-06-30$17.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-05, accession 0001356576-25-000055.Report this figure17.6Cost of revenue, Q3 FY2024, three months to 2024-09-30$17.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure26.1Cost of revenue, Q4 FY2024, three months to 2024-12-31$26.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure15.8Cost of revenue, Q1 FY2025, three months to 2025-03-31$15.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure16.8Cost of revenue, Q2 FY2025, three months to 2025-06-30$16.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure19.0Cost of revenue, Q3 FY2025, three months to 2025-09-30$19.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure23.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$23.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure23.4Cost of revenue, Q1 FY2026, three months to 2026-03-31$23.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure33.7Cost of revenue, Q2 FY2026, three months to 2026-06-30$33.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure27.0Cost of revenue, Q3 FY2026, three months to 2026-09-30$27.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure
Research and development$m23.3Research and development, period not labelled, three months to 2023-12-31$23.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure24.9Research and development, Q1 FY2024, three months to 2024-03-31$24.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0001356576-25-000033.Report this figure26.2Research and development, Q2 FY2024, three months to 2024-06-30$26.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-05, accession 0001356576-25-000055.Report this figure29.0Research and development, Q3 FY2024, three months to 2024-09-30$29.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure28.6Research and development, Q4 FY2024, three months to 2024-12-31$28.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure26.9Research and development, Q1 FY2025, three months to 2025-03-31$26.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure22.1Research and development, Q2 FY2025, three months to 2025-06-30$22.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure29.4Research and development, Q3 FY2025, three months to 2025-09-30$29.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure27.8Research and development, Q4 FY2025, three months to 2025-12-31$27.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure39.4Research and development, Q1 FY2026, three months to 2026-03-31$39.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure29.5Research and development, Q2 FY2026, three months to 2026-06-30$29.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure25.8Research and development, Q3 FY2026, three months to 2026-09-30$25.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure
Selling, general and administrative$m81.3Selling, general and administrative, period not labelled, three months to 2023-12-31$81.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure86.5Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$86.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-06, accession 0001356576-25-000033.Report this figure85.9Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$85.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-05, accession 0001356576-25-000055.Report this figure69.8Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$69.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure79.4Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$79.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure89.9Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$89.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure93.6Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$93.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure180Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$179.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure122Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$122.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure125Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$125.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure134Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$133.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure128Selling, general and administrative, Q3 FY2026, three months to 2026-09-30$128.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure
Operating income$m(1.0)Operating income, period not labelled, three months to 2023-12-31−$996.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(3.2)Operating income, Q1 FY2024, three months to 2024-03-31−$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0001356576-25-000033.Report this figure22.6Operating income, Q2 FY2024, three months to 2024-06-30$22.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0001356576-25-000055.Report this figure40.8Operating income, Q3 FY2024, three months to 2024-09-30$40.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure21.4Operating income, Q4 FY2024, three months to 2024-12-31$21.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(10.3)Operating income, Q1 FY2025, three months to 2025-03-31−$10.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure12.1Operating income, Q2 FY2025, three months to 2025-06-30$12.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure(60.2)Operating income, Q3 FY2025, three months to 2025-09-30−$60.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure(3.9)Operating income, Q4 FY2025, three months to 2025-12-31−$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(8.3)Operating income, Q1 FY2026, three months to 2026-03-31−$8.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure(58.0)Operating income, Q2 FY2026, three months to 2026-06-30−$58.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure21.2Operating income, Q3 FY2026, three months to 2026-09-30$21.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure
Interest expense$m0.0Interest expense, period not labelled, three months to 2023-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-08, accession 0001356576-24-000028.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-08-06, accession 0001356576-24-000051.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-04, accession 0001356576-24-000067.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Interest expense, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figurenot reported2.3Interest expense, Q2 FY2026, three months to 2026-06-30$2.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure0.7Interest expense, Q3 FY2026, three months to 2026-09-30$718.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure
Income tax$m(0.2)Income tax, period not labelled, three months to 2023-12-31−$185.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2024, three months to 2024-03-31$119.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0001356576-25-000033.Report this figure6.4Income tax, Q2 FY2024, three months to 2024-06-30$6.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-05, accession 0001356576-25-000055.Report this figure6.4Income tax, Q3 FY2024, three months to 2024-09-30$6.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure11.1Income tax, Q4 FY2024, three months to 2024-12-31$11.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure6.0Income tax, Q1 FY2025, three months to 2025-03-31$6.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure(5.8)Income tax, Q2 FY2025, three months to 2025-06-30−$5.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure(12.8)Income tax, Q3 FY2025, three months to 2025-09-30−$12.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure2.2Income tax, Q4 FY2025, three months to 2025-12-31$2.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(3.7)Income tax, Q1 FY2026, three months to 2026-03-31−$3.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure0.7Income tax, Q2 FY2026, three months to 2026-06-30$723.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure1.8Income tax, Q3 FY2026, three months to 2026-09-30$1.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure
Net income$m1.2Net income, period not labelled, three months to 2023-12-31$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.1Net income, Q1 FY2024, three months to 2024-03-31$124.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure19.9Net income, Q2 FY2024, three months to 2024-06-30$19.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure38.5Net income, Q3 FY2024, three months to 2024-09-30$38.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure15.3Net income, Q4 FY2024, three months to 2024-12-31$15.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(11.8)Net income, Q1 FY2025, three months to 2025-03-31−$11.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure22.5Net income, Q2 FY2025, three months to 2025-06-30$22.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure(45.1)Net income, Q3 FY2025, three months to 2025-09-30−$45.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure(4.1)Net income, Q4 FY2025, three months to 2025-12-31−$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(2.3)Net income, Q1 FY2026, three months to 2026-03-31−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure(58.4)Net income, Q2 FY2026, three months to 2026-06-30−$58.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure20.9Net income, Q3 FY2026, three months to 2026-09-30$20.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure
Diluted EPS$ per sharenot reported0.00Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0001356576-25-000033.Report this figure0.36Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0001356576-25-000055.Report this figure0.69Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.69 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figurenot reported(0.21)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure0.40Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure(0.80)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figurenot reported(0.04)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure(1.01)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure0.35Diluted EPS, Q3 FY2026, three months to 2026-09-30$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure
Basic EPS$ per sharenot reported0.00Basic EPS, Q1 FY2024, three months to 2024-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0001356576-25-000033.Report this figure0.36Basic EPS, Q2 FY2024, three months to 2024-06-30$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0001356576-25-000055.Report this figure0.70Basic EPS, Q3 FY2024, three months to 2024-09-30$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figurenot reported(0.21)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure0.40Basic EPS, Q2 FY2025, three months to 2025-06-30$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure(0.80)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figurenot reported(0.04)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure(1.01)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure0.36Basic EPS, Q3 FY2026, three months to 2026-09-30$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure

Balance sheet

Cash and equivalents$175.9m, Q3 FY2026
Shareholders' equity$1.06bn, Q3 FY2026
Supernus Pharmaceuticals, Inc., balance sheet, quarterly
Line itemUnitperiod not labelled2023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Cash and equivalents$m75.1Cash and equivalents, period not labelled, at 2023-12-31$75.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-02, accession 0001356576-26-000011.Report this figure63.4Cash and equivalents, Q1 FY2024, at 2024-03-31$63.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0001356576-24-000028.Report this figure52.1Cash and equivalents, Q2 FY2024, at 2024-06-30$52.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0001356576-24-000051.Report this figure31.7Cash and equivalents, Q3 FY2024, at 2024-09-30$31.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure69.3Cash and equivalents, FY2024, at 2024-12-31$69.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-02, accession 0001356576-26-000011.Report this figure116Cash and equivalents, Q1 FY2025, at 2025-03-31$115.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure145Cash and equivalents, Q2 FY2025, at 2025-06-30$144.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure151Cash and equivalents, Q3 FY2025, at 2025-09-30$151.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure128Cash and equivalents, FY2025, at 2025-12-31$128.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure185Cash and equivalents, Q1 FY2026, at 2026-03-31$184.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure180Cash and equivalents, Q2 FY2026, at 2026-06-30$180.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure176Cash and equivalents, Q3 FY2026, at 2026-09-30$175.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure
Current assets$m493Current assets, period not labelled, at 2023-12-31$493.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-25, accession 0001356576-25-000017.Report this figure544Current assets, Q1 FY2024, at 2024-03-31$544.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001356576-24-000028.Report this figure591Current assets, Q2 FY2024, at 2024-06-30$591.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001356576-24-000051.Report this figure640Current assets, Q3 FY2024, at 2024-09-30$640.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-04, accession 0001356576-24-000067.Report this figure686Current assets, FY2024, at 2024-12-31$686.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-02, accession 0001356576-26-000011.Report this figure688Current assets, Q1 FY2025, at 2025-03-31$687.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0001356576-25-000033.Report this figure739Current assets, Q2 FY2025, at 2025-06-30$738.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0001356576-25-000055.Report this figure594Current assets, Q3 FY2025, at 2025-09-30$593.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure644Current assets, FY2025, at 2025-12-31$644.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure732Current assets, Q1 FY2026, at 2026-03-31$731.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure723Current assets, Q2 FY2026, at 2026-06-30$723.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure711Current assets, Q3 FY2026, at 2026-09-30$711.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure
Total assets$m1,278Total assets, period not labelled, at 2023-12-31$1.28bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-25, accession 0001356576-25-000017.Report this figure1,304Total assets, Q1 FY2024, at 2024-03-31$1.30bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001356576-24-000028.Report this figure1,316Total assets, Q2 FY2024, at 2024-06-30$1.32bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001356576-24-000051.Report this figure1,343Total assets, Q3 FY2024, at 2024-09-30$1.34bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-04, accession 0001356576-24-000067.Report this figure1,368Total assets, FY2024, at 2024-12-31$1.37bn. XBRL concept us-gaap:Assets. 10-K filed 2026-03-02, accession 0001356576-26-000011.Report this figure1,347Total assets, Q1 FY2025, at 2025-03-31$1.35bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0001356576-25-000033.Report this figure1,382Total assets, Q2 FY2025, at 2025-06-30$1.38bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0001356576-25-000055.Report this figure1,420Total assets, Q3 FY2025, at 2025-09-30$1.42bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure1,453Total assets, FY2025, at 2025-12-31$1.45bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure1,501Total assets, Q1 FY2026, at 2026-03-31$1.50bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure1,428Total assets, Q2 FY2026, at 2026-06-30$1.43bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure1,398Total assets, Q3 FY2026, at 2026-09-30$1.40bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure
Current liabilities$m290Current liabilities, period not labelled, at 2023-12-31$290.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-25, accession 0001356576-25-000017.Report this figure315Current liabilities, Q1 FY2024, at 2024-03-31$314.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001356576-24-000028.Report this figure309Current liabilities, Q2 FY2024, at 2024-06-30$308.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001356576-24-000051.Report this figure292Current liabilities, Q3 FY2024, at 2024-09-30$291.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-04, accession 0001356576-24-000067.Report this figure292Current liabilities, FY2024, at 2024-12-31$292.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-02, accession 0001356576-26-000011.Report this figure282Current liabilities, Q1 FY2025, at 2025-03-31$281.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0001356576-25-000033.Report this figure286Current liabilities, Q2 FY2025, at 2025-06-30$286.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0001356576-25-000055.Report this figure331Current liabilities, Q3 FY2025, at 2025-09-30$330.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure338Current liabilities, FY2025, at 2025-12-31$338.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure374Current liabilities, Q1 FY2026, at 2026-03-31$373.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure347Current liabilities, Q2 FY2026, at 2026-06-30$347.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure285Current liabilities, Q3 FY2026, at 2026-09-30$285.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure
Total liabilities$m356Total liabilities, period not labelled, at 2023-12-31$356.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-25, accession 0001356576-25-000017.Report this figure375Total liabilities, Q1 FY2024, at 2024-03-31$374.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0001356576-24-000028.Report this figure358Total liabilities, Q2 FY2024, at 2024-06-30$358.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001356576-24-000051.Report this figure336Total liabilities, Q3 FY2024, at 2024-09-30$335.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-04, accession 0001356576-24-000067.Report this figure332Total liabilities, FY2024, at 2024-12-31$332.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-02, accession 0001356576-26-000011.Report this figure317Total liabilities, Q1 FY2025, at 2025-03-31$316.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0001356576-25-000033.Report this figure319Total liabilities, Q2 FY2025, at 2025-06-30$318.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0001356576-25-000055.Report this figure370Total liabilities, Q3 FY2025, at 2025-09-30$370.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure391Total liabilities, FY2025, at 2025-12-31$390.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure424Total liabilities, Q1 FY2026, at 2026-03-31$423.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure397Total liabilities, Q2 FY2026, at 2026-06-30$396.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure335Total liabilities, Q3 FY2026, at 2026-09-30$335.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m922Shareholders' equity, period not labelled, at 2023-12-31$921.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-02, accession 0001356576-26-000011.Report this figure929Shareholders' equity, Q1 FY2024, at 2024-03-31$929.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure957Shareholders' equity, Q2 FY2024, at 2024-06-30$957.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure1,007Shareholders' equity, Q3 FY2024, at 2024-09-30$1.01bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure1,036Shareholders' equity, FY2024, at 2024-12-31$1.04bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure1,031Shareholders' equity, Q1 FY2025, at 2025-03-31$1.03bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure1,064Shareholders' equity, Q2 FY2025, at 2025-06-30$1.06bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure1,050Shareholders' equity, Q3 FY2025, at 2025-09-30$1.05bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure1,062Shareholders' equity, FY2025, at 2025-12-31$1.06bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure1,077Shareholders' equity, Q1 FY2026, at 2026-03-31$1.08bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure1,031Shareholders' equity, Q2 FY2026, at 2026-06-30$1.03bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure1,062Shareholders' equity, Q3 FY2026, at 2026-09-30$1.06bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure

Cash flow

Operating cash flow$6.6m, Q3 FY2026
Capital expenditure$230.0k, Q3 FY2026
Supernus Pharmaceuticals, Inc., cash flow, quarterly
Line itemUnitperiod not labelled2023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Operating cash flow$m45.0Operating cash flow, period not labelled, three months to 2023-12-31$45.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure38.4Operating cash flow, Q1 FY2024, three months to 2024-03-31$38.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0001356576-25-000033.Report this figure35.6Operating cash flow, Q2 FY2024, three months to 2024-06-30$35.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0001356576-25-000055. Derived: 6-month figure less the 3-month figure.Report this figure53.5Operating cash flow, Q3 FY2024, three months to 2024-09-30$53.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001356576-25-000071. Derived: 9-month figure less the 6-month figure.Report this figure44.4Operating cash flow, Q4 FY2024, three months to 2024-12-31$44.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure30.6Operating cash flow, Q1 FY2025, three months to 2025-03-31$30.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure58.5Operating cash flow, Q2 FY2025, three months to 2025-06-30$58.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001356576-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure(61.7)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$61.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001356576-26-000051. Derived: 9-month figure less the 6-month figure.Report this figure19.9Operating cash flow, Q4 FY2025, three months to 2025-12-31$19.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure66.5Operating cash flow, Q1 FY2026, three months to 2026-03-31$66.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure(4.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001356576-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure6.6Operating cash flow, Q3 FY2026, three months to 2026-09-30$6.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-29, accession 0001356576-26-000051. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m(0.0)Capital expenditure, period not labelled, three months to 2023-12-31−$36.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$248.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0001356576-25-000033.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$64.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0001356576-25-000055. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$200.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001356576-25-000071. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$213.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2025, three months to 2025-03-31$327.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure0.5Capital expenditure, Q2 FY2025, three months to 2025-06-30$455.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001356576-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$129.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001356576-26-000051. Derived: 9-month figure less the 6-month figure.Report this figure0.4Capital expenditure, Q4 FY2025, three months to 2025-12-31$427.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001356576-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure0.6Capital expenditure, Q2 FY2026, three months to 2026-06-30$568.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001356576-26-000037. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2026, three months to 2026-09-30$230.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-29, accession 0001356576-26-000051. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)59.47m, Q3 FY2026
Supernus Pharmaceuticals, Inc., shares, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30
Diluted shares (weighted)m shares62.5Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3162,454,204 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001356576-24-000028.Report this figure54.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3054,502,993 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001356576-24-000051.Report this figure54.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3054,608,963 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-04, accession 0001356576-24-000067.Report this figure55.6Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3155,626,663 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0001356576-25-000033.Report this figure55.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3055,724,283 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0001356576-25-000055.Report this figure56.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3056,016,350 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001356576-25-000071.Report this figure55.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3155,864,692 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure56.6Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3056,643,189 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure56.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3056,552,741 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure57.6Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3157,647,548 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001356576-26-000022.Report this figure58.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3058,070,378 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001356576-26-000037.Report this figure59.5Diluted shares (weighted), Q3 FY2026, three months to 2026-09-3059,471,021 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure

Shares outstanding: 58.24mShares outstanding, period not labelled, at 2026-10-2758,235,716 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-10-29, accession 0001356576-26-000051.Report this figure at Oct 27, 2026, from the cover of the 10-Q filed Oct 29, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 17:38 ET. Listed shows no prices and gives no investment advice.